AR and prostate cancer: LncRNAs have been established to play important roles in many oncogenic events in genitourinary diseases, including androgen receptor signaling pathway in prostate cancer, hypoxia-inducible factor regulatory network in renal cell carcinoma and tumor invasion in bladder cancer, as well as other underlying molecular mechanisms involved in survival and proliferation [16].